Pharmacomechanical Thrombectomy and Catheter-Directed Thrombolysis, with or without Iliac Vein Stenting, in the Treatment of Acute Iliofemoral Deep Vein Thrombosis.
Evren ÖzçınarNur DikmenAhmet KayanMelisa KandemirMehmet Cahit SarıcaoğluPublished in: Journal of cardiovascular development and disease (2024)
Pharmacomechanical thrombectomy (PMCT) combined with catheter-directed thrombolysis (CDT) therapy has shown significant efficacy in alleviating leg symptoms and reducing the occurrence of post-thrombotic syndrome (PTS), including the incidence of moderate-to-severe PTS. On the other hand, the utilization of PMCT + CDT + stent therapy, tailored to individual patients' clinical and venous conditions, may enhance long-term venous patency and lead to superior outcomes, including improved quality of life parameters.
Keyphrases
- acute ischemic stroke
- pulmonary embolism
- end stage renal disease
- ejection fraction
- newly diagnosed
- liver failure
- risk factors
- drug induced
- ultrasound guided
- early onset
- type diabetes
- stem cells
- respiratory failure
- smoking cessation
- case report
- sleep quality
- mesenchymal stem cells
- combination therapy
- depressive symptoms
- bone marrow
- patient reported
- acute respiratory distress syndrome
- physical activity
- percutaneous coronary intervention
- endovascular treatment